Physician profile
Abigail E Stein
NPI 1902268659
$449.77
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $100 · 2021: $153 · 2022: $69.64 · 2023: $57.93 · 2024: $69.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $127.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $93.75 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $90.96 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $65.64 | 2020-2023 | Vaxneuvance, Proquad, Gardasil 9 |
| Ironshore Pharmaceuticals INC. | $48.97 | 2020-2022 | |
| Pfizer INC. | $42.65 | 2023-2024 | |
| Abbvie INC. | $32.28 | 2024 | |
| Glaxosmithkline, LLC. | $25.42 | 2021-2022 | |
| Corium, LLC | $22.28 | 2023 | Azstarys |
| Sanofi Pasteur INC. | $14.83 | 2024 | |
| Dermira, INC. | $12.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abigail Stein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.